File Download

Conference Paper: Cost-effectiveness of apixaban versus warfarin in chinese patients with non-valvular atrial fibrillation

TitleCost-effectiveness of apixaban versus warfarin in chinese patients with non-valvular atrial fibrillation
Authors
Issue Date2016
Citation
The ISPOR 7th Asia-Pacific Conference (ISPOR-ASIA 2016), Singapore, 3-6 September 2016. How to Cite?
AbstractOBJECTIVES: To evaluate the cost-effectiveness of apixaban versus warfarin in Chinese patients with non-valvular atrial fibrillation (NVAF) from the Hong Kong public institutional perspective ...
Persistent Identifierhttp://hdl.handle.net/10722/229971

 

DC FieldValueLanguage
dc.contributor.authorChan, EW-
dc.contributor.authorLi, X-
dc.contributor.authorLau, CY-
dc.contributor.authorAnand, S-
dc.date.accessioned2016-08-23T14:14:24Z-
dc.date.available2016-08-23T14:14:24Z-
dc.date.issued2016-
dc.identifier.citationThe ISPOR 7th Asia-Pacific Conference (ISPOR-ASIA 2016), Singapore, 3-6 September 2016.-
dc.identifier.urihttp://hdl.handle.net/10722/229971-
dc.description.abstractOBJECTIVES: To evaluate the cost-effectiveness of apixaban versus warfarin in Chinese patients with non-valvular atrial fibrillation (NVAF) from the Hong Kong public institutional perspective ...-
dc.languageeng-
dc.relation.ispartofISPOR 7th Asia-Pacific Conference, ISPOR-ASIA 2016-
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License-
dc.titleCost-effectiveness of apixaban versus warfarin in chinese patients with non-valvular atrial fibrillation-
dc.typeConference_Paper-
dc.identifier.emailChan, EW: ewchan@hku.hk-
dc.identifier.emailLi, X: sxueli@hku.hk-
dc.identifier.emailLau, CY: wallisy@hku.hk-
dc.identifier.emailAnand, S: shweta@hku.hk-
dc.identifier.authorityChan, EW=rp01587-
dc.description.naturepostprint-
dc.identifier.hkuros260542-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats